Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts

被引:44
|
作者
Graff, Rebecca E. [1 ,2 ,3 ]
Cavazos, Taylor B. [4 ]
Thai, Khanh K. [2 ]
Kachuri, Linda [1 ]
Rashkin, Sara R. [1 ]
Hoffman, Joshua D. [1 ]
Alexeeff, Stacey E. [2 ]
Blatchins, Maruta [2 ]
Meyers, Travis J. [1 ]
Leong, Lancelote [1 ]
Tai, Caroline G. [1 ]
Emami, Nima C. [1 ,4 ]
Corley, Douglas A. [2 ]
Kushi, Lawrence H. [2 ]
Ziv, Elad [3 ,5 ,6 ]
Van den Eeden, Stephen K. [2 ,7 ]
Jorgenson, Eric [2 ]
Hoffmann, Thomas J. [1 ,2 ,5 ]
Habel, Laurel A. [2 ]
Witte, John S. [1 ,3 ,5 ,7 ]
Sakoda, Lori C. [2 ,8 ]
机构
[1] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[2] Kaiser Permanente Northern Calif, Div Res, Oakland, CA 94611 USA
[3] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Program Biol & Med Informat, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA
[6] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[7] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA
[8] Kaiser Permanente Bernard J Tyson Sch Med, Dept Hlth Syst Sci, Pasadena, CA 91101 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/s41467-021-21288-z
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Even distinct cancer types share biological hallmarks. Here, we investigate polygenic risk score (PRS)-specific pleiotropy across 16 cancers in European ancestry individuals from the Genetic Epidemiology Research on Adult Health and Aging cohort (16,012 cases, 50,552 controls) and UK Biobank (48,969 cases, 359,802 controls). Within cohorts, each PRS is evaluated in multivariable logistic regression models against all other cancer types. Results are then meta-analyzed across cohorts. Ten positive and one inverse cross-cancer associations are found after multiple testing correction. Two pairs show bidirectional associations; the melanoma PRS is positively associated with oral cavity/pharyngeal cancer and vice versa, whereas the lung cancer PRS is positively associated with oral cavity/pharyngeal cancer, and the oral cavity/pharyngeal cancer PRS is inversely associated with lung cancer. Overall, we validate known, and uncover previously unreported, patterns of pleiotropy that have the potential to inform investigations of risk prediction, shared etiology, and precision cancer prevention strategies. While genetic loci shared between cancer types have been identified, cross-cancer relationships for polygenic risk scores have not been well studied. Here, the authors have developed polygenic risk scores for 16 cancers in two large cohorts and identified positive and inverse cross-cancer associations.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Development and evaluation of polygenic risk scores for prediction of endometrial cancer risk in European women
    Bafligil, Cemsel
    Thompson, Deborah J.
    Lophatananon, Artitaya
    Ryan, Neil A. J.
    Smith, Miriam J.
    Dennis, Joe
    Mekli, Krisztina
    O'Mara, Tracy A.
    Evans, D. Gareth
    Crosbie, Emma J.
    [J]. GENETICS IN MEDICINE, 2022, 24 (09) : 1847 - 1856
  • [22] Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study
    Yang, Xin
    Leslie, Goska
    Gentry-Maharaj, Aleksandra
    Ryan, Andy
    Intermaggio, Maria
    Lee, Andrew
    Kalsi, Jatinderpal K.
    Tyrer, Jonathan
    Gaba, Faiza
    Manchanda, Ranjit
    Pharoah, Paul D. P.
    Gayther, Simon A.
    Ramus, Susan J.
    Jacobs, Ian
    Menon, Usha
    Antoniou, Antonis C.
    [J]. JOURNAL OF MEDICAL GENETICS, 2018, 55 (08) : 546 - 554
  • [23] Polygenic Risk Scores in Prostate Cancer Risk Assessment and Screening
    Byrne, Lindsey
    Toland, Amanda Ewart
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2021, 48 (03) : 387 - 399
  • [24] Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
    Mavaddat, Nasim
    Michailidou, Kyriaki
    Dennis, Joe
    Lush, Michael
    Fachal, Laura
    Lee, Andrew
    Tyrer, Jonathan P.
    Chen, Ting-Huei
    Wang, Qin
    Bolla, Manjeet K.
    Yang, Xin
    Adank, Muriel A.
    Ahearn, Thomas
    Aittomaki, Kristiina
    Allen, Jamie
    Andrulis, Irene L.
    Anton-Culver, Hoda
    Antonenkova, Natalia N.
    Arndt, Volker
    Aronson, Kristan J.
    Auer, Paul L.
    Auvinen, Paivi
    Barrdahl, Myrto
    Freeman, Laura E. Beane
    Beckmann, Matthias W.
    Behrens, Sabine
    Benitez, Javier
    Bermisheva, Marina
    Bernstein, Leslie
    Blomqvist, Carl
    Bogdanova, Natalia, V
    Bojesen, Stig E.
    Bonanni, Bernardo
    Borresen-Dale, Anne-Lise
    Brauch, Hiltrud
    Bremer, Michael
    Brenner, Hermann
    Brentnall, Adam
    Brock, Ian W.
    Brooks-Wilson, Angela
    Brucker, Sara Y.
    Bruening, Thomas
    Burwinkel, Barbara
    Campa, Daniele
    Carter, Brian D.
    Castelao, Jose E.
    Chanock, Stephen J.
    Chlebowski, Rowan
    Christiansen, Hans
    Clarke, Christine L.
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2019, 104 (01) : 21 - 34
  • [25] Assessing thyroid cancer risk using polygenic risk scores
    Liyanarachchi, Sandya
    Gudmundsson, Julius
    Ferkingstad, Egil
    He, Huiling
    Jonasson, Jon G.
    Tragante, Vinicius
    Asselbergs, Folkert W.
    Xu, Li
    Kiemeney, Lambertus A.
    Netea-Maier, Romana T.
    Mayordomo, Jose I.
    Plantinga, Theo S.
    Hjartarson, Hannes
    Hrafnkelsson, Jon
    Sturgis, Erich M.
    Brock, Pamela
    Nabhan, Fadi
    Thorleifsson, Gudmar
    Ringel, Matthew D.
    Stefansson, Kari
    de la Chapelle, Albert
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (11) : 5997 - 6002
  • [26] Will polygenic risk scores for cancer ever be clinically useful?
    Amit Sud
    Clare Turnbull
    Richard Houlston
    [J]. npj Precision Oncology, 5
  • [27] Will polygenic risk scores for cancer ever be clinically useful?
    Sud, Amit
    Turnbull, Clare
    Houlston, Richard
    [J]. NPJ PRECISION ONCOLOGY, 2021, 5 (01)
  • [28] Are polygenic risk scores ready for the cancer clinic?-a perspective
    Klein, Robert J.
    Gumus, Zeynep H.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (05) : 910 - 919
  • [29] Bringing Prostate Cancer Polygenic Risk Scores to the Clinic
    Klein, Robert J. J.
    [J]. JAMA INTERNAL MEDICINE, 2023, 183 (04) : 388 - 389
  • [30] Cross-cancer evaluation of MYC synthetic lethal targets in The Cancer Genome Atlas
    Bernard, Brady
    Cermelli, Silvia
    Grandori, Carla
    Shmulevich, Ilya
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (05)